HomeNewsBusinessMarketsDon’t wait for a bull market; focus on consumption, financials and IT sectors: Virendra Somwanshi

Don’t wait for a bull market; focus on consumption, financials and IT sectors: Virendra Somwanshi

It will be advisable to build equity portfolios for the long term as per your risk profile by staggering investments over six to 12 months, says Somwanshi.

May 13, 2020 / 12:18 IST
Story continues below Advertisement

Instead of waiting for the next bull market, it is advisable to build equity portfolios for the long term by staggering investments over next six to 12 months, Virendra Somwanshi, Managing Director & CEO,  Motilal Oswal Private Wealth Management, says in an interview to Moneycontrol’s Kshitij Anand.

Edited excerpts:

Story continues below Advertisement

Q) We are just two months into a bear market and expecting a bottom (at 7,500) could be too optimistic. Could we be looking at another leg of downswing before we stabilise?
A) The biggest uncertainty today is the availability of a ‘vaccine’. The market is reacting a lot to fear psychosis, uncertainty, and news flow and very less to do with fundamentals.

In the short term, markets will continue to be volatile to the news flows coming from the UK and the US (since it is the risk capital of the world), any incremental actions were taken by the government to reboot the economy through fiscal packages and by any RBI measures to provide further relief to the financial system.

Early results of Q4FY20 earnings season and management commentaries suggest more disruption in earnings ahead with several Nifty companies seeing EPS cuts for FY21.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show